EPHB2 and neoplasm: These tumours have a CpG Island Methylator Phenotype (CIMP) characterized by the hypermethylation of tumour suppressor gene promoters, like EPHB2, leading to overactivation of MAPK pathway, and a high level of MSI [10,11,12].